These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Elevation of Early Plasma Biomarkers in Patients with Clinical Risk Factors Predicts Increased Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation. Hotta M; Satake A; Yoshimura H; Fujita S; Katayama Y; Ota S; Hanamoto H; Oyake T; Ito S; Okada M; Nakanishi T; Ito T; Ishii K; Nomura S Transplant Cell Ther; 2021 Aug; 27(8):660.e1-660.e8. PubMed ID: 33989832 [TBL] [Abstract][Full Text] [Related]
18. Engraftment syndrome after allogeneic stem cell transplantation: a systematic review and meta-analysis. ElGohary G; Toor AA; Gergis U Bone Marrow Transplant; 2023 Jan; 58(1):1-9. PubMed ID: 36284212 [TBL] [Abstract][Full Text] [Related]
19. Increased Late Noncardiac Nonrelapse Mortality in Patients with Atrial Fibrillation Diagnosed During Their Hospital Stay for Allogeneic Stem Cell Transplantation. Lueck C; Panagiota V; Dammann E; Gabdoulline R; Berliner D; Veltmann C; Heuser M; Beutel G; Ganser A; Eder M Transplant Cell Ther; 2022 Sep; 28(9):609.e1-609.e8. PubMed ID: 35724849 [TBL] [Abstract][Full Text] [Related]
20. Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation. Baron F; Labopin M; Niederwieser D; Vigouroux S; Cornelissen JJ; Malm C; Vindelov LL; Blaise D; Janssen JJ; Petersen E; Socié G; Nagler A; Rocha V; Mohty M Leukemia; 2012 Dec; 26(12):2462-8. PubMed ID: 22699419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]